RAPT Therapeutics (NASDAQ:RAPT) Azioni

RAPT THERAPEUTICS INC

RAPT Therapeutics

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

RAPT Therapeutics Inc

News

Legal

Press Releases

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against RAPT Therapeutics, Inc. and Encourages Investors to Contact the Firm

Earnings

RAPT Therapeutics Reports Second Quarter 2024 Financial Results

Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury

RAPT Therapeutics Reports Third Quarter 2024 Financial Results

RAPT Therapeutics and Shanghai Jemincare Pharmaceutical Announce Exclusive License Agreement for Novel Long-Acting anti-IgE Antibody

RAPT Therapeutics Announces $150 Million Private Placement

Management

RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company's Board of Directors

RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

RAPT Therapeutics to Participate in Upcoming Investor Conferences

CTNM

RAPT

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share

Amarin Corp

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Genfit

TuHURA Biosciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Inventiva S.A. - American Depository Shares

Inventiva

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Korro Bio

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

Lyell Immunopharma

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nanobiotix

Neurogene

Puma Biotechnology

Rezolute

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Protara Therapeutics, Inc. - Common Stock

Protara Therapeutics

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Tango Therapeutics

Tevogen Bio Holdings

Voyager Therapeutics, Inc. - Common Stock

Comments

RAPT Therapeutics

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO